Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
When would you consider upfront eculizumab for sickle cell hyperhemolysis?
How long after eculizumab infusion would you wait before giving blood transfusions?
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
What experience have you had with familial clustering of polycythemia vera?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Can lupus anticoagulant be positive despite a normal aPTT?
How would you manage aplastic anemia refractory to multiple agents?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?